How Did I Get Chlamydia if My Partner Didn’t Cheat?

Chlamydia can appear in a monogamous relationship without anyone having been unfaithful. The most common explanation is that one or both partners were already carrying the infection from a previous relationship without knowing it, since chlamydia can persist silently for years. But that is only one of several possibilities, and the biology behind this bacterium makes the picture more complicated than most people realize.

Silent Infections That Predate Your Relationship

The single most likely explanation for a chlamydia diagnosis in a committed relationship is that one partner was already infected before the relationship started. Chlamydia is often called a “silent” infection because most people who have it experience no symptoms at all. Without testing, there is no way to know it is there. And here is the part that surprises people: it can stay there for a very long time. Clinicians have argued that in the absence of antibiotics taken for any reason or prior chlamydia-specific testing, an asymptomatic woman has roughly a one-in-four chance of having carried the infection for two or more years. That means someone could have acquired chlamydia from a partner they dated years ago and only discover it now.¹

Part of why chlamydia lingers is biological. When the bacterium faces stress from the immune system or certain environmental conditions, it can stop dividing and enter a dormant, “aberrant” state inside your cells. In this form, it essentially pauses its life cycle and hunkers down, avoiding immune detection for extended periods.² The body does sometimes clear chlamydia on its own. In one study, about 22% of women had spontaneously resolved their infection by the time they enrolled.³ But that leaves the majority carrying the infection until it is treated. Someone whose body did not spontaneously clear the bacterium could easily bring an old, symptom-free infection into a new relationship.

When Previous Treatment Didn’t Fully Work

Another scenario that does not involve cheating: you or your partner was treated for chlamydia in the past, but the treatment did not completely eliminate the infection. This is more common than you might expect, particularly with azithromycin, the single-dose antibiotic that used to be the go-to treatment. A meta-analysis found that azithromycin has a failure rate roughly two percentage points higher than doxycycline, which may sound small but adds up across a large population.⁴

The gap becomes more dramatic for rectal chlamydia infections. In a study of women treated at STI clinics, azithromycin cured only about 79% of rectal infections, compared to roughly 96% for doxycycline.⁵ A separate trial found no treatment failures at all in the doxycycline group, while about 3% of participants treated with azithromycin still tested positive afterward.⁶ If either of you was ever treated with a single dose of azithromycin and never retested afterward, it is entirely possible that the infection was never fully cleared, especially at a rectal site that may not have even been tested.

Testing Has Real Limitations

Tests for chlamydia are good, but they are not perfect. The type of sample collected makes a real difference. A meta-analysis comparing vaginal swabs with urine samples in women found that urine testing had a sensitivity of about 87% for chlamydia, meaning roughly 13 out of every 100 positive cases would be missed.⁷ In men, urine self-samples compared to clinician-collected urethral samples also showed a sensitivity of about 88%.⁸ So a clean test result from a urine sample does not guarantee someone is infection-free. A person could have tested negative at one point, believed they were clear, and actually been carrying the bacterium the entire time.

On the other end, false positives can also occur. Research has shown that confirming positive results with a second, independent test can significantly reduce or eliminate false-positive results.⁹ This is rare with modern testing, but if you are in a situation where the diagnosis simply does not match what you know about your relationship, asking your provider about confirmatory testing is a reasonable step.

Another testing blind spot involves site-specific infections. Standard chlamydia screening typically tests the genital tract, but the bacterium can also live in the rectum and throat. In one study of men who have sex with men, over half of chlamydia infections were found at non-urethral sites and would have been completely missed by standard urethral screening alone.¹⁰ This applies to anyone who has had oral or anal contact. A throat or rectal infection that was never tested for could persist undetected and later be passed to a partner through sexual contact within the relationship.

A Positive Test After Treatment Doesn’t Always Mean Reinfection

If you or your partner was recently treated for chlamydia and then tested positive again, the instinct is to assume someone picked it up from a new exposure. But the test itself can be misleading in the weeks after treatment. Modern tests detect the genetic material of the bacterium, and fragments of that genetic material can linger even after the bacteria are dead. One study found that the median time to a first negative result after treatment was about nine days, but some individuals still tested positive by DNA detection for weeks afterward, with some not clearing until day 84.¹¹ By three weeks after treatment, about 89% of patients had a negative result, meaning roughly one in ten was still testing positive despite successful treatment.

Researchers have described occasional “blips” of detectable genetic material even after clearance, which could result from degrading cells releasing fragments or even from non-viable material deposited during sex with a partner who was also treated.¹² This is why most guidelines recommend waiting at least three to four weeks before retesting after treatment. Testing too soon can produce a positive result that reflects dead bacteria, not a new infection.

One Partner Can Test Positive While the Other Tests Negative

Here is something that catches couples off guard: even when both partners have clearly been exposed, they do not always test the same way. In the largest study to date on chlamydia within heterosexual couples, about 76% of men and 77% of women tested positive when their partner was positive.¹³ That means roughly one in four exposed partners tested negative. Some of these people may have cleared the infection on their own, some may have had an infection load too low to detect, and some may have had other factors working in their favor. The same study found that men were less likely to be infected if their female partner had recently taken antibiotics for any reason, suggesting that incidental antibiotic use can sometimes prevent transmission without anyone realizing it.

The takeaway: a negative test in one partner does not prove they were never exposed, and it does not prove the positive partner acquired the infection from someone else. Biology is more variable than a yes-or-no test result implies.

Vaginal Health Affects Whether Chlamydia Sticks Around

The vaginal microbiome plays a surprisingly large role in chlamydia persistence. Bacterial vaginosis, a common condition where the protective bacteria in the vagina are outnumbered by other microorganisms, has been consistently linked to higher rates of chlamydia persistence and susceptibility. In a longitudinal study, women with bacterial vaginosis had about 1.9 times the odds of their chlamydia persisting rather than clearing spontaneously, and within-participant analysis pushed that number even higher.¹⁴

The connection runs in the other direction too. Women who had normal vaginal flora with hydrogen peroxide-producing lactobacilli were less likely to test positive for chlamydia when exposed to a male partner with urethritis.¹⁵ And in a large cohort of women in the U.S. Army, every additional episode of bacterial vaginosis raised the risk of acquiring chlamydia by about 13%.¹⁶ This means that a person’s underlying vaginal health can independently affect whether chlamydia takes hold, how long it persists, and whether the body clears it. It is another factor that has nothing to do with sexual behavior.

Why Treating Both Partners Matters

Even once you know how the infection got there, the practical question becomes what to do about it. One of the biggest drivers of chlamydia recurrence is not treatment failure or reinfection from outside the relationship. It is one partner getting treated while the other does not, leading to a cycle of passing the same infection back and forth. This is why expedited partner therapy exists: the idea that the diagnosed person can bring medication home for their partner without the partner needing a separate clinic visit.

A large trial found that patients whose partners received expedited treatment had lower rates of persistent or recurrent infection compared to those who relied on standard partner referral, where the partner is told to go to a clinic themselves. The difference was driven largely by gonorrhea outcomes, while the reduction for chlamydia specifically was more modest.¹⁷ Program evaluations generally show that expedited partner therapy increases the likelihood that partners actually get treated, even if reductions in reinfection do not always reach statistical significance.¹⁸ A more recent study using electronic medical records found that patients who received expedited partner therapy had a slightly lower rate of reinfection at follow-up, though the difference was not large enough to rule out chance.¹⁹

The bottom-line practical point: both partners need to be treated at the same time and should avoid sexual contact until treatment is complete for both. Even in a faithful relationship, skipping the partner’s treatment virtually guarantees the infection will bounce back.

What About Non-Sexual Transmission

People sometimes wonder whether chlamydia can be picked up from a toilet seat, a towel, or some other environmental source. The evidence here is clear: non-sexual transmission of chlamydia in adults is an infrequent occurrence.²⁰ The bacterium is fragile and does not survive well outside the human body. For practical purposes, adults do not catch chlamydia from casual contact or contaminated surfaces.

There is one genuine non-sexual route, however: from mother to child during birth. Chlamydia-positive infants face a meaningfully higher risk of perinatal pneumonia.²¹ The estimated range of vertical transmission has been cited as anywhere from 10% to 70% of deliveries by positive mothers, though neonatal chlamydia infections are rarely encountered in routine clinical practice, possibly because many are mild or self-resolving.²² This route is relevant mainly for newborns, not for explaining how an adult contracted the infection.

The Stigma Problem

The reason this question feels so loaded is that chlamydia carries social stigma that far outweighs its medical severity. It is one of the most common bacterial infections worldwide, easily treated with a course of antibiotics, and in most cases causes no permanent harm when caught in time. Yet a diagnosis often triggers immediate suspicion in relationships because people assume that a positive STI test means recent sexual contact with someone new.

Research into the emotional experience of STI diagnoses bears this out. Studies of young adults have found that people perceived significant stigma around simply getting tested for STIs, let alone receiving a positive result. Participants reported that they would feel uncomfortable disclosing an STI to sexual partners and especially to parents, and that they believed their community would treat them differently if testing became known.²³ That shame often translates into avoidance of testing altogether, which ironically allows silent infections to persist longer and increases the very scenario this article describes.

If you are in a relationship where a chlamydia diagnosis has created tension, the biology outlined above is worth sharing. The infection could easily predate the relationship by years. The test could have limitations. Previous treatment may have failed silently. These are not rationalizations or excuses. They are well-documented features of how this particular bacterium behaves, and any clinician familiar with chlamydia would tell you the same thing.

Different Strains Behave Differently

Not all chlamydia is created equal. Most genital infections are caused by serovars D through K, which produce superficial mucosal infections and are the type most people think of when they hear “chlamydia.” But a separate group of strains, serovars L1 through L3, cause lymphogranuloma venereum, a more aggressive condition that invades lymph nodes and can progress through distinct phases including painful swelling and tissue destruction if untreated.²⁴ Lymphogranuloma venereum is more common in anorectal infections and requires a longer antibiotic course than standard chlamydia.²⁵

For the person wondering how they got chlamydia, the strain distinction matters because standard treatment may not be adequate for all strains at all sites. If someone received a short course of azithromycin for what turned out to be an anorectal infection with an aggressive strain, the chances of treatment failure go up. And if neither partner nor provider thought to test rectally, an infection at that site could have persisted undetected through what everyone assumed was adequate treatment.